APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Coagulation Factor VIII

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.

Selected research

Industry Research

Human Coagulation Factor VIII Industry Research Report 2026

8 January 2026125 pages

Choose your research edition.

Industry ResearchHuman Coagulation Factor VIII Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Coagulation Factor VIII Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Human Coagulation Factor VIII Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Coagulation Factor VIII Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Coagulation Factor VIII Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.

Global Human Coagulation Factor VIII key players include Baxter, Bayer, CSL, Pfizer, Biogen, etc. Global top five manufacturers hold a share about 80%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 30 percent. In terms of product, Recombinant Factor VIII is the largest segment, with a share about 65%. And in terms of application, the largest application is Hemophilia A, followed by Spontanous / Trauma, Surgical, etc.

Report Scope

Read the full market overview

This report quantifies the global Human Coagulation Factor VIII market in terms of revenue (US$ million) and, where applicable, sales volume (K Bottles), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Bottles) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Human Coagulation Factor VIII Market by Company

Shire (Baxter)

Bayer

CSL

Pfizer

Grifols

Biogen

Octapharma

NovoNordisk

Greencross

Kedrion

BPL

Hualan Bio

RAAS

Human Coagulation Factor VIII Segment by Type

Recombinant Factor VIII

Plasma-derived Factor VIII

Human Coagulation Factor VIII Segment by Application

Hemophilia A

Spontanous / Trauma

Surgical

Other

Human Coagulation Factor VIII Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor VIII.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Human Coagulation Factor VIII by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Human Coagulation Factor VIII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Human Coagulation Factor VIII Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Human Coagulation Factor VIII Sales (K Bottles) of Manufacturers (2021-2026) Table 7. Global Human Coagulation Factor VIII Sales Market Share by Manufacturers (2021-2026) Table 8. Global Human Coagulation Factor VIII Revenue of Manufacturers (2021-2026) Table 9. Global Human Coagulation Factor VIII Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Human Coagulation Factor VIII Average Price (USD/Bottle) of Manufacturers (2021-2026) Table 11. Global Human Coagulation Factor VIII Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Human Coagulation Factor VIII, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Human Coagulation Factor VIII, Product Type & Application Table 14. Global Human Coagulation Factor VIII Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Human Coagulation Factor VIII by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Shire (Baxter) Company Information Table 19. Shire (Baxter) Business Overview Table 20. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 21. Shire (Baxter) Human Coagulation Factor VIII Product Portfolio Table 22. Shire (Baxter) Recent Developments Table 23. Bayer Company Information Table 24. Bayer Business Overview Table 25. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 26. Bayer Human Coagulation Factor VIII Product Portfolio Table 27. Bayer Recent Developments Table 28. CSL Company Information Table 29. CSL Business Overview Table 30. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 31. CSL Human Coagulation Factor VIII Product Portfolio Table 32. CSL Recent Developments Table 33. Pfizer Company Information Table 34. Pfizer Business Overview Table 35. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 36. Pfizer Human Coagulation Factor VIII Product Portfolio Table 37. Pfizer Recent Developments Table 38. Grifols Company Information Table 39. Grifols Business Overview Table 40. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 41. Grifols Human Coagulation Factor VIII Product Portfolio Table 42. Grifols Recent Developments Table 43. Biogen Company Information Table 44. Biogen Business Overview Table 45. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 46. Biogen Human Coagulation Factor VIII Product Portfolio Table 47. Biogen Recent Developments Table 48. Octapharma Company Information Table 49. Octapharma Business Overview Table 50. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 51. Octapharma Human Coagulation Factor VIII Product Portfolio Table 52. Octapharma Recent Developments Table 53. NovoNordisk Company Information Table 54. NovoNordisk Business Overview Table 55. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 56. NovoNordisk Human Coagulation Factor VIII Product Portfolio Table 57. NovoNordisk Recent Developments Table 58. Greencross Company Information Table 59. Greencross Business Overview Table 60. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 61. Greencross Human Coagulation Factor VIII Product Portfolio Table 62. Greencross Recent Developments Table 63. Kedrion Company Information Table 64. Kedrion Business Overview Table 65. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 66. Kedrion Human Coagulation Factor VIII Product Portfolio Table 67. Kedrion Recent Developments Table 68. BPL Company Information Table 69. BPL Business Overview Table 70. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 71. BPL Human Coagulation Factor VIII Product Portfolio Table 72. BPL Recent Developments Table 73. Hualan Bio Company Information Table 74. Hualan Bio Business Overview Table 75. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 76. Hualan Bio Human Coagulation Factor VIII Product Portfolio Table 77. Hualan Bio Recent Developments Table 78. RAAS Company Information Table 79. RAAS Business Overview Table 80. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 81. RAAS Human Coagulation Factor VIII Product Portfolio Table 82. RAAS Recent Developments Table 83. Global Human Coagulation Factor VIII Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 84. Global Human Coagulation Factor VIII Sales by Region (2021-2026) & (K Bottles) Table 85. Global Human Coagulation Factor VIII Sales Market Share by Region (2021-2026) Table 86. Global Human Coagulation Factor VIII Sales by Region (2027-2032) & (K Bottles) Table 87. Global Human Coagulation Factor VIII Sales Market Share by Region (2027-2032) Table 88. Global Human Coagulation Factor VIII Revenue by Region (2021-2026) & (US$ Million) Table 89. Global Human Coagulation Factor VIII Revenue Market Share by Region (2021-2026) Table 90. Global Human Coagulation Factor VIII Revenue by Region (2027-2032) & (US$ Million) Table 91. Global Human Coagulation Factor VIII Revenue Market Share by Region (2027-2032) Table 92. North America Human Coagulation Factor VIII Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. North America Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles) Table 94. North America Human Coagulation Factor VIII Sales by Country (2027-2032) & (K Bottles) Table 95. North America Human Coagulation Factor VIII Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Human Coagulation Factor VIII Revenue by Country (2027-2032) & (US$ Million) Table 97. Europe Human Coagulation Factor VIII Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Europe Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles) Table 99. Europe Human Coagulation Factor VIII Sales by Country (2027-2032) & (K Bottles) Table 100. Europe Human Coagulation Factor VIII Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Human Coagulation Factor VIII Revenue by Country (2027-2032) & (US$ Million) Table 102. Asia Pacific Human Coagulation Factor VIII Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Asia Pacific Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles) Table 104. Asia Pacific Human Coagulation Factor VIII Sales by Country (2027-2032) & (K Bottles) Table 105. Asia Pacific Human Coagulation Factor VIII Revenue by Country (2021-2026) & (US$ Million) Table 106. Asia Pacific Human Coagulation Factor VIII Revenue by Country (2027-2032) & (US$ Million) Table 107. South America Human Coagulation Factor VIII Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. South America Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles) Table 109. South America Human Coagulation Factor VIII Sales by Country (2027-2032) & (K Bottles) Table 110. South America Human Coagulation Factor VIII Revenue by Country (2021-2026) & (US$ Million) Table 111. South America Human Coagulation Factor VIII Revenue by Country (2027-2032) & (US$ Million) Table 112. Middle East and Africa Human Coagulation Factor VIII Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles) Table 114. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2027-2032) & (K Bottles) Table 115. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2021-2026) & (US$ Million) Table 116. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2027-2032) & (US$ Million) Table 117. Global Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles) Table 118. Global Human Coagulation Factor VIII Sales by Type (2027-2032) & (K Bottles) Table 119. Global Human Coagulation Factor VIII Sales Market Share by Type (2021-2026) Table 120. Global Human Coagulation Factor VIII Sales Market Share by Type (2027-2032) Table 121. Global Human Coagulation Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 122. Global Human Coagulation Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 123. Global Human Coagulation Factor VIII Revenue Market Share by Type (2021-2026) Table 124. Global Human Coagulation Factor VIII Revenue Market Share by Type (2027-2032) Table 125. Global Human Coagulation Factor VIII Price by Type (2021-2026) & (USD/Bottle) Table 126. Global Human Coagulation Factor VIII Price by Type (2027-2032) & (USD/Bottle) Table 127. Global Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles) Table 128. Global Human Coagulation Factor VIII Sales by Application (2027-2032) & (K Bottles) Table 129. Global Human Coagulation Factor VIII Sales Market Share by Application (2021-2026) Table 130. Global Human Coagulation Factor VIII Sales Market Share by Application (2027-2032) Table 131. Global Human Coagulation Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 132. Global Human Coagulation Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 133. Global Human Coagulation Factor VIII Revenue Market Share by Application (2021-2026) Table 134. Global Human Coagulation Factor VIII Revenue Market Share by Application (2027-2032) Table 135. Global Human Coagulation Factor VIII Price by Application (2021-2026) & (USD/Bottle) Table 136. Global Human Coagulation Factor VIII Price by Application (2027-2032) & (USD/Bottle) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Human Coagulation Factor VIII Distributors List Table 140. Human Coagulation Factor VIII Customers List Table 141. Human Coagulation Factor VIII Industry Trends Table 142. Human Coagulation Factor VIII Industry Drivers Table 143. Human Coagulation Factor VIII Industry Restraints Table 144. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Human Coagulation Factor VIII Product Image Figure 5. Global Human Coagulation Factor VIII Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Human Coagulation Factor VIII Market Size (2021-2032) & (US$ Million) Figure 7. Global Human Coagulation Factor VIII Sales (2021-2032) & (K Bottles) Figure 8. Global Human Coagulation Factor VIII Average Price (USD/Bottle) & (2021-2032) Figure 9. Recombinant Factor VIII Product Image Figure 10. Plasma-derived Factor VIII Product Image Figure 11. Hemophilia A Product Image Figure 12. Spontanous / Trauma Product Image Figure 13. Surgical Product Image Figure 14. Other Product Image Figure 15. Global Human Coagulation Factor VIII Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Human Coagulation Factor VIII, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Human Coagulation Factor VIII Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Human Coagulation Factor VIII Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Human Coagulation Factor VIII Sales by Region in 2025 Figure 21. Global Human Coagulation Factor VIII Revenue by Region in 2025 Figure 22. North America Human Coagulation Factor VIII Market Size by Country in 2025 Figure 23. North America Human Coagulation Factor VIII Sales Market Share by Country (2021-2032) Figure 24. North America Human Coagulation Factor VIII Revenue Market Share by Country (2021-2032) Figure 25. United States Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Human Coagulation Factor VIII Market Size by Country in 2025 Figure 29. Europe Human Coagulation Factor VIII Sales Market Share by Country (2021-2032) Figure 30. Europe Human Coagulation Factor VIII Revenue Market Share by Country (2021-2032) Figure 31. Germany Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Human Coagulation Factor VIII Market Size by Country in 2025 Figure 42. Asia Pacific Human Coagulation Factor VIII Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Human Coagulation Factor VIII Revenue Market Share by Country (2021-2032) Figure 44. China Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Human Coagulation Factor VIII Market Size by Country in 2025 Figure 53. South America Human Coagulation Factor VIII Sales Market Share by Country (2021-2032) Figure 54. South America Human Coagulation Factor VIII Revenue Market Share by Country (2021-2032) Figure 55. Brazil Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Human Coagulation Factor VIII Market Size by Country in 2025 Figure 59. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Human Coagulation Factor VIII Revenue Market Share by Country (2021-2032) Figure 61. Egypt Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Human Coagulation Factor VIII Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Human Coagulation Factor VIII Sales Market Share by Type (2021-2032) Figure 67. Global Human Coagulation Factor VIII Revenue Market Share by Type (2021-2032) Figure 68. Global Human Coagulation Factor VIII Price (USD/Bottle) by Type (2021-2032) Figure 69. Global Human Coagulation Factor VIII Sales Market Share by Application (2021-2032) Figure 70. Global Human Coagulation Factor VIII Revenue Market Share by Application (2021-2032) Figure 71. Global Human Coagulation Factor VIII Price (USD/Bottle) by Application (2021-2032) Figure 72. Human Coagulation Factor VIII Value Chain Figure 73. Human Coagulation Factor VIII Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Human Coagulation Factor VIII Industry Opportunities and Challenges

Scope & coverage.

Types
  • Recombinant Factor VIII
  • Plasma-derived Factor VIII
Applications
  • Hemophilia A
  • Spontanous / Trauma
  • Surgical
  • Other
Companies covered
  • Shire (Baxter)
  • Bayer
  • CSL
  • Pfizer
  • Grifols
  • Biogen
  • Octapharma
  • NovoNordisk
  • Greencross
  • Kedrion
  • BPL
  • Hualan Bio
  • RAAS

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Human Coagulation Factor VIII Market Size (2021-2032)
  4. 2.2.2 Global Human Coagulation Factor VIII Sales (2021-2032)
  5. 2.2.3 Global Human Coagulation Factor VIII Market Average Price (2021-2032)
  6. 2.3 Human Coagulation Factor VIII by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Recombinant Factor VIII
  9. 2.3.3 Plasma-derived Factor VIII
  10. 2.4 Human Coagulation Factor VIII by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hemophilia A
  13. 2.4.3 Spontanous / Trauma
  14. 2.4.4 Surgical
  15. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Human Coagulation Factor VIII Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Human Coagulation Factor VIII Sales (K Bottles) of Manufacturers (2021-2026)
  3. 3.3 Global Human Coagulation Factor VIII Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Human Coagulation Factor VIII Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Human Coagulation Factor VIII Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Human Coagulation Factor VIII, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Human Coagulation Factor VIII, Product Type & Application
  8. 3.8 Global Manufacturers of Human Coagulation Factor VIII, Established Date
  9. 3.9 Global Human Coagulation Factor VIII Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Shire (Baxter)
  2. 4.1.1 Shire (Baxter) Company Information
  3. 4.1.2 Shire (Baxter) Business Overview
  4. 4.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
  6. 4.1.5 Shire (Baxter) Recent Developments
  7. 4.2 Bayer
  8. 4.2.1 Bayer Company Information
  9. 4.2.2 Bayer Business Overview
  10. 4.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Bayer Human Coagulation Factor VIII Product Portfolio
  12. 4.2.5 Bayer Recent Developments
  13. 4.3 CSL
  14. 4.3.1 CSL Company Information
  15. 4.3.2 CSL Business Overview
  16. 4.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 CSL Human Coagulation Factor VIII Product Portfolio
  18. 4.3.5 CSL Recent Developments
  19. 4.4 Pfizer
  20. 4.4.1 Pfizer Company Information
  21. 4.4.2 Pfizer Business Overview
  22. 4.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Pfizer Human Coagulation Factor VIII Product Portfolio
  24. 4.4.5 Pfizer Recent Developments
  25. 4.5 Grifols
  26. 4.5.1 Grifols Company Information
  27. 4.5.2 Grifols Business Overview
  28. 4.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Grifols Human Coagulation Factor VIII Product Portfolio
  30. 4.5.5 Grifols Recent Developments
  31. 4.6 Biogen
  32. 4.6.1 Biogen Company Information
  33. 4.6.2 Biogen Business Overview
  34. 4.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Biogen Human Coagulation Factor VIII Product Portfolio
  36. 4.6.5 Biogen Recent Developments
  37. 4.7 Octapharma
  38. 4.7.1 Octapharma Company Information
  39. 4.7.2 Octapharma Business Overview
  40. 4.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Octapharma Human Coagulation Factor VIII Product Portfolio
  42. 4.7.5 Octapharma Recent Developments
  43. 4.8 NovoNordisk
  44. 4.8.1 NovoNordisk Company Information
  45. 4.8.2 NovoNordisk Business Overview
  46. 4.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 NovoNordisk Human Coagulation Factor VIII Product Portfolio
  48. 4.8.5 NovoNordisk Recent Developments
  49. 4.9 Greencross
  50. 4.9.1 Greencross Company Information
  51. 4.9.2 Greencross Business Overview
  52. 4.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Greencross Human Coagulation Factor VIII Product Portfolio
  54. 4.9.5 Greencross Recent Developments
  55. 4.10 Kedrion
  56. 4.10.1 Kedrion Company Information
  57. 4.10.2 Kedrion Business Overview
  58. 4.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Kedrion Human Coagulation Factor VIII Product Portfolio
  60. 4.10.5 Kedrion Recent Developments
  61. 4.11 BPL
  62. 4.11.1 BPL Company Information
  63. 4.11.2 BPL Business Overview
  64. 4.11.3 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 BPL Human Coagulation Factor VIII Product Portfolio
  66. 4.11.5 BPL Recent Developments
  67. 4.12 Hualan Bio
  68. 4.12.1 Hualan Bio Company Information
  69. 4.12.2 Hualan Bio Business Overview
  70. 4.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Hualan Bio Human Coagulation Factor VIII Product Portfolio
  72. 4.12.5 Hualan Bio Recent Developments
  73. 4.13 RAAS
  74. 4.13.1 RAAS Company Information
  75. 4.13.2 RAAS Business Overview
  76. 4.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 RAAS Human Coagulation Factor VIII Product Portfolio
  78. 4.13.5 RAAS Recent Developments
5 Global Human Coagulation Factor VIII Market Scenario by Region
  1. 5.1 Global Human Coagulation Factor VIII Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Human Coagulation Factor VIII Sales by Region: 2021-2032
  3. 5.2.1 Global Human Coagulation Factor VIII Sales by Region: 2021-2026
  4. 5.2.2 Global Human Coagulation Factor VIII Sales by Region: 2027-2032
  5. 5.3 Global Human Coagulation Factor VIII Revenue by Region: 2021-2032
  6. 5.3.1 Global Human Coagulation Factor VIII Revenue by Region: 2021-2026
  7. 5.3.2 Global Human Coagulation Factor VIII Revenue by Region: 2027-2032
  8. 5.4 North America Human Coagulation Factor VIII Market Facts & Figures by Country
  9. 5.4.1 North America Human Coagulation Factor VIII Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Human Coagulation Factor VIII Sales by Country (2021-2032)
  11. 5.4.3 North America Human Coagulation Factor VIII Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Human Coagulation Factor VIII Market Facts & Figures by Country
  16. 5.5.1 Europe Human Coagulation Factor VIII Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Human Coagulation Factor VIII Sales by Country (2021-2032)
  18. 5.5.3 Europe Human Coagulation Factor VIII Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Human Coagulation Factor VIII Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Human Coagulation Factor VIII Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Human Coagulation Factor VIII Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Human Coagulation Factor VIII Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Human Coagulation Factor VIII Market Facts & Figures by Country
  41. 5.7.1 South America Human Coagulation Factor VIII Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Human Coagulation Factor VIII Sales by Country (2021-2032)
  43. 5.7.3 South America Human Coagulation Factor VIII Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Human Coagulation Factor VIII Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Human Coagulation Factor VIII Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Human Coagulation Factor VIII Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Human Coagulation Factor VIII Sales by Type (2021-2032)
  2. 6.1.1 Global Human Coagulation Factor VIII Sales by Type (2021-2032) & (K Bottles)
  3. 6.1.2 Global Human Coagulation Factor VIII Sales Market Share by Type (2021-2032)
  4. 6.2 Global Human Coagulation Factor VIII Revenue by Type (2021-2032)
  5. 6.2.1 Global Human Coagulation Factor VIII Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Human Coagulation Factor VIII Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Human Coagulation Factor VIII Sales by Application (2021-2032)
  2. 7.1.1 Global Human Coagulation Factor VIII Sales by Application (2021-2032) & (K Bottles)
  3. 7.1.2 Global Human Coagulation Factor VIII Sales Market Share by Application (2021-2032)
  4. 7.2 Global Human Coagulation Factor VIII Revenue by Application (2021-2032)
  5. 7.2.1 Global Human Coagulation Factor VIII Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Human Coagulation Factor VIII Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Human Coagulation Factor VIII Value Chain Analysis
  2. 8.1.1 Human Coagulation Factor VIII Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Human Coagulation Factor VIII Production Mode & Process
  5. 8.2 Human Coagulation Factor VIII Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Human Coagulation Factor VIII Distributors
  8. 8.2.3 Human Coagulation Factor VIII Customers
9 Global Human Coagulation Factor VIII Analyzing Market Dynamics
  1. 9.1 Human Coagulation Factor VIII Industry Trends
  2. 9.2 Human Coagulation Factor VIII Industry Drivers
  3. 9.3 Human Coagulation Factor VIII Industry Opportunities and Challenges
  4. 9.4 Human Coagulation Factor VIII Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst